Amoxicillin, Clavulanate Potassium
Penbraya is a pentavalent meningococcal vaccine developed by Pfizer that provides protection against five major serogroups of Neisseria meningitidis bacteria (A, B, C, W, and Y). This vaccine is approved for active immunization to prevent invasive meningococcal disease in individuals aged 10 through 25 years. It combines multiple antigenic components to offer broad coverage against the most common disease-causing meningococcal strains.
Penbraya is a meningococcal vaccine for adolescents and young adults (ages 10-25) that protects against five major serogroups of bacteria causing invasive meningococcal disease.
Key facts at a glance
- RxNorm
- 2670561
- Generic
- Penbraya
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Penbraya is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y in individuals 10 through 25 years of age. It is commonly recommended for adolescents, particularly those entering college or university, as they may be at increased risk due to close living quarters.
Penbraya is a conjugate vaccine that contains antigens from multiple meningococcal serogroups. It works by stimulating the immune system to produce antibodies against the bacterial components, enabling the body to recognize and fight the bacteria if exposed. This provides active acquired immunity against the covered serogroups.
As with all vaccines, Penbraya may not provide complete protection for all recipients. Common side effects include injection site pain, headache, and fatigue. Vaccination history and individual health factors should be discussed with a healthcare provider. Penbraya may be administered as a single dose or according to specific dosing schedules based on individual risk factors and prior vaccination status.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy